Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

OVP Venture Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 118
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 56
Rounds per year 2.95
Lead investments 29
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.53
Exits 32
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Software
  • Biotechnology
  • Health Care
  • Enterprise Software
  • Advertising
Summary

OVP Venture Partners appeared to be the VC, which was created in 1983. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Seattle.

The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Cradlepoint, RedSeal, VLST Corporation

The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the OVP Venture Partners, startups are often financed by Ignition Partners, Yaletown Partners, Sevin Rosen Funds. The meaningful sponsors for the fund in investment in the same round are Yaletown Partners, GrowthWorks Capital, Amgen Ventures. In the next rounds fund is usually obtained by Ignition Partners, Yaletown Partners, GrowthWorks Capital.

The average startup value when the investment from OVP Venture Partners is 50-100 millions dollars. The high activity for fund was in 2007. Despite it in 2019 the fund had an activity. The real fund results show that this VC is 14 percentage points more often commits exit comparing to other companies. The top amount of exits for fund were in 2014. Opposing the other organizations, this OVP Venture Partners works on 2 percentage points less the average amount of lead investments. The fund is constantly included in 2-6 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The overall number of key employees were 3.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of OVP Venture Partners:
Typical Co-investors
OVP Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after OVP Venture Partners:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Group14 Technologies

Battery
Chemical
Chemical Engineering
Manufacturing
Nanotechnology
$17M21 Dec 2020 Washington, United States

Group14 Technologies

Battery
Chemical
Chemical Engineering
Manufacturing
Nanotechnology
$18M09 Aug 2019 Washington, United States

Symform

Cloud Computing
Cloud Data Services
Web Hosting
$11M25 Apr 2012 Seattle, Washington, United States

Biopharma
Biotechnology
Medical
$6M12 Dec 2011 Seattle, Washington, United States

Oncofactor

Biotechnology
Health Care
Therapeutics
$2M02 Aug 2011 Seattle, Washington, United States

PrecisionDemand

Advertising
Advertising Platforms
Marketing
$8M29 Jul 2011 Seattle, Washington, United States

Fate Therapeutics

Biotechnology
Health Care
Therapeutics
$36M05 May 2011 San Diego, California, United States

Acylin Therapeutics

Biotechnology
Drug Discovery
Manufacturing
Pharmaceutical
Pharmaceuticals
Therapeutics
$4M11 Jan 2011 Seattle, Washington, United States

CarbonFlow

GreenTech
Software
$4M28 Oct 2010 San Francisco, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent OVP Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 118
Average round size 10M
Rounds per year 2.95
Peak activity year 2007
Lead investments 29
Follow on index 0.53
Exits 32
Group Appearance index 0.91

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Group14 Technologies

Battery
Chemical
Chemical Engineering
Manufacturing
Nanotechnology
$17M21 Dec 2020 Washington, United States

Group14 Technologies

Battery
Chemical
Chemical Engineering
Manufacturing
Nanotechnology
$18M09 Aug 2019 Washington, United States

Symform

Cloud Computing
Cloud Data Services
Web Hosting
$11M25 Apr 2012 Seattle, Washington, United States

Biopharma
Biotechnology
Medical
$6M12 Dec 2011 Seattle, Washington, United States

Oncofactor

Biotechnology
Health Care
Therapeutics
$2M02 Aug 2011 Seattle, Washington, United States

PrecisionDemand

Advertising
Advertising Platforms
Marketing
$8M29 Jul 2011 Seattle, Washington, United States

Fate Therapeutics

Biotechnology
Health Care
Therapeutics
$36M05 May 2011 San Diego, California, United States

Acylin Therapeutics

Biotechnology
Drug Discovery
Manufacturing
Pharmaceutical
Pharmaceuticals
Therapeutics
$4M11 Jan 2011 Seattle, Washington, United States

CarbonFlow

GreenTech
Software
$4M28 Oct 2010 San Francisco, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: